Robin Jones
罗宾·琼斯
MBBS, PhD
Professor of Sarcoma Oncology and Consultant Medical Oncologist肉瘤肿瘤学教授兼肿瘤内科顾问
👥Biography 个人简介
Leading UK expert in soft tissue sarcoma and trabectedin clinical development. Led or co-led the ANNOUNCE trial and multiple international sarcoma studies, establishing trabectedin's role in leiomyosarcoma and advancing novel systemic therapies for advanced soft tissue sarcomas.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Trabectedin in Soft Tissue Sarcoma
Co-led the ANNOUNCE phase 3 trial of doxorubicin plus trabectedin in untreated advanced soft tissue sarcoma, providing critical data on combination regimens and informing the use of trabectedin in leiomyosarcoma.
Representative Works 代表性著作
Randomized Phase III Study of Doxorubicin Plus Olaratumab Versus Doxorubicin Plus Placebo in Patients with Advanced Soft Tissue Sarcomas (ANNOUNCE)
Journal of Clinical Oncology (2020)
Definitive phase 3 trial that did not confirm the benefit of olaratumab, reshaping first-line treatment approaches in advanced STS.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 罗宾·琼斯 的研究动态
Follow Robin Jones's research updates
留下邮箱，当我们发布与 Robin Jones（Royal Marsden Hospital / Institute of Cancer Research）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment